These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21203949)

  • 21. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug design targeting the main protease, the Achilles' heel of coronaviruses.
    Yang H; Bartlam M; Rao Z
    Curr Pharm Des; 2006; 12(35):4573-90. PubMed ID: 17168763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
    Tan J; Verschueren KH; Anand K; Shen J; Yang M; Xu Y; Rao Z; Bigalke J; Heisen B; Mesters JR; Chen K; Shen X; Jiang H; Hilgenfeld R
    J Mol Biol; 2005 Nov; 354(1):25-40. PubMed ID: 16242152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 polyprotein substrate regulates the stepwise M
    Narwal M; Armache JP; Edwards TJ; Murakami KS
    J Biol Chem; 2023 May; 299(5):104697. PubMed ID: 37044215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2.
    Zhao Y; Zhu Y; Liu X; Jin Z; Duan Y; Zhang Q; Wu C; Feng L; Du X; Zhao J; Shao M; Zhang B; Yang X; Wu L; Ji X; Guddat LW; Yang K; Rao Z; Yang H
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117142119. PubMed ID: 35380892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.
    Lee TW; Cherney MM; Huitema C; Liu J; James KE; Powers JC; Eltis LD; James MN
    J Mol Biol; 2005 Nov; 353(5):1137-51. PubMed ID: 16219322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
    Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
    Koudelka T; Boger J; Henkel A; Schönherr R; Krantz S; Fuchs S; Rodríguez E; Redecke L; Tholey A
    Proteomics; 2021 Jan; 21(2):e2000246. PubMed ID: 33111431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site.
    Lee J; Worrall LJ; Vuckovic M; Rosell FI; Gentile F; Ton AT; Caveney NA; Ban F; Cherkasov A; Paetzel M; Strynadka NCJ
    Nat Commun; 2020 Nov; 11(1):5877. PubMed ID: 33208735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.
    Yang H; Yang M; Ding Y; Liu Y; Lou Z; Zhou Z; Sun L; Mo L; Ye S; Pang H; Gao GF; Anand K; Bartlam M; Hilgenfeld R; Rao Z
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13190-5. PubMed ID: 14585926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease.
    Cooper MS; Zhang L; Ibrahim M; Zhang K; Sun X; Röske J; Göhl M; Brönstrup M; Cowell JK; Sauerhering L; Becker S; Vangeel L; Jochmans D; Neyts J; Rox K; Marsh GP; Maple HJ; Hilgenfeld R
    J Med Chem; 2022 Oct; 65(19):13328-13342. PubMed ID: 36179320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.
    De Marco Verissimo C; López Corrales J; Dorey AL; Cwiklinski K; Lalor R; Calvani NED; Jewhurst HL; Flaus A; Doyle S; Dalton JP
    Epidemiol Infect; 2022 Jun; 150():e128. PubMed ID: 35723031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease.
    MacDonald EA; Frey G; Namchuk MN; Harrison SC; Hinshaw SM; Windsor IW
    ACS Infect Dis; 2021 Sep; 7(9):2591-2595. PubMed ID: 34437808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide.
    Du QS; Wang SQ; Zhu Y; Wei DQ; Guo H; Sirois S; Chou KC
    Peptides; 2004 Nov; 25(11):1857-64. PubMed ID: 15501516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI
    Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.
    Du Q; Wang S; Jiang Z; Gao W; Li Y; Wei D; Chou KC
    Med Chem; 2005 May; 1(3):209-13. PubMed ID: 16787316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topological analysis of SARS CoV-2 main protease.
    Estrada E
    Chaos; 2020 Jun; 30(6):061102. PubMed ID: 32611087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.
    Fischer A; Sellner M; Neranjan S; Smieško M; Lill MA
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.